ContraFect (NASDAQ:CFRX) reported quarterly losses of $(0.46) per share. This is a 228.57 percent decrease over losses of $(0.14) per share from the same period last year.
PetVivo Reports FY23 Full Year Financial Results; FY23 EPS $(0.85) Vs $(0.57) YoY; Revenue $917,162 Vs $115,586 YoY
For The Fiscal Year Ended March 31, 2023 Compared to The Fiscal Year Ended March 31, 2022
Total Revenues. Revenues were $917,162 in fiscal 2023 compared